Natriumcitrat Grifols (Sodium Citrate)

Sodium citrate, the active ingredient in Natriumcitrat Grifols, is an anticoagulant presented as a solution for extracorporeal use. It provides calcium chelation to prevent clot formation during procedures such as hemodialysis and plasma exchange. GNH USA supplies Natriumcitrat Grifols as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, dialysis centres, transplant centres and specialized clinics worldwide.

Sodium citrate is employed as an anticoagulant in extracorporeal circuits and related renal replacement therapies.

Hemodialysis: maintains circuit patency by chelating calcium and preventing clot formation. Continuous renal replacement therapy (CRRT): provides anticoagulation for prolonged dialysis sessions. Plasma exchange: reduces clot risk during plasma apheresis procedures.

Sodium citrate may cause several adverse reactions, ranging from mild to serious, depending on the extent of calcium depletion and individual sensitivity.

Common Side Effects: - Hypocalcemia: transient low calcium levels causing tingling or muscle cramps. - Metallic taste in the mouth. - Nausea or mild gastrointestinal discomfort. - Vomiting. - Mild hypotension during infusion.

Serious or Rare Side Effects: - Severe hypocalcemia leading to cardiac arrhythmia or seizures. - Allergic reactions such as rash, urticaria, or anaphylaxis.

When using sodium citrate, careful monitoring and specific precautions are recommended to ensure patient safety.

Patient monitoring: check ionized calcium levels regularly during treatment. Electrolyte balance: assess for symptoms of hypocalcemia and correct as needed. Renal function: consider dose adjustment in severe renal impairment. Concurrent anticoagulants: avoid overlapping anticoagulant therapy without medical supervision. Pregnancy and lactation: use only if the potential benefits justify the potential risks. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Sodium citrate can interact with other agents that affect calcium balance or coagulation pathways.

Major Interactions (Avoid): - Calcium supplements: counteract the anticoagulant effect of citrate. - Vitamin D analogues: may increase serum calcium and reduce efficacy. - Other anticoagulants (e.g., heparin, citrate‑containing solutions): risk of excessive anticoagulation.

Moderate Interactions (Monitor Closely): - Loop diuretics: may enhance calcium loss and potentiate hypocalcemia. - Beta‑agonists: potential additive hypotensive effect during infusion.